On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
HOME > REGULATORY
REGULATORY
- Gov’t to Decide on Extension of Urgent Vaccination Project “as Soon as Possible”
November 30, 2011
- MLHW Announces Extension of Reexamination Period for Lonasen
November 29, 2011
- JAN Determined for 8 Drug Candidate Compounds
November 29, 2011
- Record 101 Generics from 30 Companies Listed for Aricept
November 29, 2011
- MHLW Says Sept Drug Price Settlement Rate Dips to 78.1%, Falling Below 2009 Level
November 28, 2011
- MHLW Issues Notification on Modifications of Approval for Iressa
November 28, 2011
- CSIMC to Discuss Additional Price Cuts for Long-Listed Drugs
November 28, 2011
- DPJ's Subcommittee for PAL Amendment Begins Deliberations Nov. 28, to Compile Opinion by End-Jan
November 25, 2011
- Obligatory Use of Generics for Welfare Recipients to Be Discussed: Policy Screening
November 25, 2011
- HPB, HSB Issue Notification to Ensure Stable Supplies of Flu Drugs This Season
November 25, 2011
- Experts Call For Establishment of Independent Vaccine Policy Organization
November 25, 2011
- Otsuka to Challenge Grand Champion Santen in Market for Dry Eye Treatments
November 25, 2011
- Policy Screening Committee Proposes Major Cutbacks in Long-Listed Drug Prices, Additional Decreases Possible
November 24, 2011
- Patients’ Copayments for OTC-like Drugs to Be Increased on a Trial Basis: Policy Screening
November 24, 2011
- Council Approves New 10-Year Strategy for Hepatitis Research
November 24, 2011
- MHLW Council Approves Subsidizing Telaprevir Combination Therapy
November 24, 2011
- DPJ WT to Propose New Measures to Promote Generics
November 24, 2011
- Committee on OTC Drugs Recommends SSP’s Vaginal Candidiasis Treatment for Approval
November 24, 2011
- Korosho Issues Notification to Ensure Stable Supplies of Flu Drugs This Season
November 24, 2011
- Korosho’s Council Approves Subsidizing 3-Drug Combination Therapy Including Teraprevir
November 22, 2011
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
As Japan’s budget season draws near, the Ministry of Finance (MOF) has renewed its push for a full-scale “off-year” drug…
Japan will trim the NHI price of Eli Lilly Japan’s Alzheimer’s treatment Kisunla (donanemab) by 3.93% under the cost-effectiveness assessment…
Japan is set to add 16 new drugs to its NHI reimbursement price list on November 13, including a subcutaneous…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…